Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Director/PDMR Shareholding

13 Nov 2013 16:33

RNS Number : 9668S
Amphion Innovations PLC
13 November 2013
 



 

Directors' DealingsDirectors Receive Shares in Lieu of Fees

London and New York, 13 November 2013- Amphion Innovations plc (the "Company") (LSE: AMP), the developer of medical and technology businesses, announces that the Company has today issued 663,821 ordinary shares, representing 0.45% of the enlarged issued share capital, to certain of its Board members as their directors' fees for the fourth quarter of 2012 and the first three quarters of 2013, priced at 4.175 pence, being the average of the closing mid-market price for the five days leading up to the market close on 12 November 2013.Following this issue, the directors' shareholdings in the Company are as follows:

Director

Number of New Shares

Total Shareholding

Percentage of voting rights

R. James Macaleer

501,321

24,480,266

16.666%

Gerard Moufflet

162,500

862,500

0.587%

Director, Anthony Henfrey waived his fees for the fourth quarter of 2012 as well as for the first three quarters of 2013.

Admission of the 663,821 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 19 November 2013. Following this allotment the total issued share capital of the Company will increase to 146,884,071 ordinary shares with each share holding one voting right.

 

For further information please contact

Amphion InnovationsCharlie Morgan+1 212 210 6224

Novella Communications Tim Robertson / Ben Heath+44 020 3151 7008

Panmure Gordon Limited Freddy Crossley / Grishma Patel (Corporate Finance)Adam Pollock (Corporate Broking)+44 020 7886 2500

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: www.amphionplc.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQXLFFXFFXFBL

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.